FDA Approves Gleevec for Type of Childhood Leukemia
The US Food and Drug Administration (FDA) has approved Gleevec (imatinib) to treat children who are newly diagnosed with a form of acute lymphoblastic leukemia (ALL).
Study Helps Define Treatment Options in Children With Hard-to-Treat Leukemias
For some children with acute lymphocytic leukemia (ALL) who don’t improve after initial induction therapy, more chemotherapy may work better than a stem cell transplant, according to a study.
CT Scans in Children Raise Risk of Cancer
Computed tomography (CT) scans in children have been linked to a small increased risk for later developing leukemia and brain cancer, according to a newly published study by international researchers.
Childhood Leukemia Survival Rates Improve Significantly
A new study shows that children with the most common type of childhood cancer, acute lymphoblastic leukemia (ALL) have a survival rate of more than 90%.
Manufacturer Releasing Emergency Supplies of Methotrexate
A maker of the cancer drug methotrexate, Bedford Laboratories, has advised the FDA that it will release emergency supplies of preservative-free methotrexate to meet patients’ needs.
World Health Organization Says Cell Phones a Possible Cause of Cancer
The International Agency for Research on Cancer has concluded that using cell phones may possibly cause cancer.
Experts See Progress, Hope in Battle Against Childhood Cancers
Survival has improved dramatically for kids with cancer over the past 30 years.
Major Study Complicates Debate over Cell Phone Use and Cancer Risk
Results from a major international study released Monday do not establish a definitive link between cell phone use and cancer, but they don’t rule one out, either.
TNF Blockers May Increase Lymphoma Risk in Kids
Kids and teens treated with drugs called tumor necrosis factor (TNF) blockers may be at an increased risk for lymphoma and other cancers, according to the US Food and Drug Administration (FDA), which is updating black box warnings for the drugs.